Here’s How Investors Get Tricked into Buying Companies Like Valeant

While half the trick of investing is figuring out what the consensus thinks, the wisdom of crowds is a myth when it comes to the markets. Case in point, Valeant Pharmaceuticals has cratered since October 2015, but many investors cling to the belief that the company's problems will be solved. Some hedge funds have (or had until the stock collapsed) as much as 20% to 30% of their capital in the company, which is extraordinarily reckless. But it's all in the numbers. The masses are missing these figures, but you don't have to... Tags: how to invest , pharma stocks , Stocks , stocks to watch , Valeant , Valeant Pharmaceuticals , VRX stock , Wall Street To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2016 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Here’s How Investors Get Tricked into Buying Companies Like Valeant appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.